Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hepatitis C 4Carcinoma, Hepatocellular 3Respiratory Tract Infections 2Leukemia, Myeloid, Acute 2Respiratory Syncytial Virus Infections 1Recurrence 1Pneumonia 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Liver Diseases 1Infections 1Hepatitis 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Bronchiolitis Obliterans Syndrome 1

Interventions

Ribavirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Respiratory Syncytial Virus Infections × Ribavirin × Clear all
NCT01502072 2021-02-15

Respiratory Syncytial Virus - RSV Protocol

M.D. Anderson Cancer Center

Phase 2 Completed
48 enrolled 11 charts

Neoplasms, Pneumonia, Respiratory Tract Infections, Respiratory Syncytial Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡